Beijing Taichuang Biotechnology Co.
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- Undisclosed
Investors
- 3
About Beijing Taichuang Biotechnology Co.
, Ltd. is a biotech company that focuses on the development of biosynthetic technology. Dr. Zhang Zhiqian, the founder of the company, graduated from Sun Yat-Sen University. As of 2022, the company has more than 80 employees, including about 30 R&D personnel. The company focuses on the development of microbial cells in the beauty, food and beverage, household cleaning and other fields. Its main products include small molecule peptides and erythritol. The company's Tidetron Altra platform strain library enables directed evolution of microbial cells through the design and construction of synthetic pathways. In 2021, the company's operating income reached nearly CNY 100 million.
Who invested in Beijing Taichuang Biotechnology Co.
3 investors across 3 rounds
See all investors in Beijing Taichuang Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Taichuang Biotechnology Co.
Who invested in Beijing Taichuang Biotechnology Co.?
Beijing Taichuang Biotechnology Co. has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Taichuang Biotechnology Co. raised?
Beijing Taichuang Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Taichuang Biotechnology Co. last raise money?
Beijing Taichuang Biotechnology Co.'s most recent round on record is a Series A, in Mar 2022.
What does Beijing Taichuang Biotechnology Co. do?
Beijing Taichuang Biotechnology Co. is a biotechnology company.
Where is Beijing Taichuang Biotechnology Co. headquartered?
Beijing Taichuang Biotechnology Co. is headquartered in Guangzhou, China.
Which VCs invest in companies like Beijing Taichuang Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Taichuang Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beijing Taichuang Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.